# V1 Empirics Check — qwen/qwen3.5-397b-a17b (Variant A)

**Model:** qwen/qwen3.5-397b-a17b
**Variant:** A
**Date:** 2026-03-23T15:28:47.014739

---

# Referee Report

**Manuscript:** The Access Cost That Wasn't: WIC EBT Mandates, Vendor Exits, and Infant Health
**Journal:** AER: Insights

## 1. Idea Fidelity

The paper pursues the core thematic question outlined in the Original Idea Manifest: estimating the causal effect of WIC EBT adoption on infant health via the vendor access channel. However, there are significant deviations from the proposed design parameters that materially affect the contribution.

First, the **data source** differs substantially. The manifest confirmed access to CDC Natality Detail Files (county-level microdata, ~68 million births), yet the paper utilizes County Health Rankings (CHR) aggregated state-level data (~765 observations). This represents a drastic reduction in statistical power and granularity. Second, the **identification strategy** omits two key components proposed in the manifest: the Bartik IV (interacting EBT timing with pre-period independent vendor share) and the Ohio county-level phased rollout analysis. The paper relies solely on state-level staggered DiD. Third, the **outcome variables** are narrowed; the manifest proposed birth weight means, preterm birth, and breastfeeding initiation, while the paper focuses exclusively on low birth weight (LBW) rates. While the central question remains intact, the empirical execution is considerably less ambitious than the feasibility check promised.

## 2. Summary

This paper investigates whether the mandated transition to Electronic Benefit Transfer (EBT) in the WIC program, which induced independent vendor exits, adversely affected infant health. Using a staggered difference-in-differences design on state-level panel data (2010–2024), the author finds no statistically significant evidence that EBT adoption increased low birth weight rates. The results suggest that while vendor consolidation occurred, it did not translate into measurable nutritional harm at the aggregate state level, implying that safety net modernization may not carry the hypothesized "access cost."

## 3. Essential Points

1.  **Data Granularity and Statistical Power:** The shift from CDC microdata (manifest) to CHR state aggregates (paper) severely limits identification. CHR data are constructed from multi-year averages (often 3-year rolling windows) to ensure stability in smaller states. This smoothing attenuates variation precisely when needed for staggered DiD, making it difficult to pinpoint the timing of treatment effects. With only 51 states and 15 time periods, the analysis is underpowered to detect modest effects, increasing the risk of Type II errors (false nulls). The manifest's feasibility grade of "READY" for county-level microdata suggests this limitation was avoidable.
2.  **Identification of the Mechanism (Vendor Exits vs. EBT):** The research question hinges on the "Infrastructure Access Multiplier"—specifically, whether *vendor exits* harm health. However, the current specification identifies the effect of *EBT adoption*. EBT adoption correlates with vendor exits but also reduces fraud, reduces stigma, and improves payment reliability. Without the proposed Bartik IV (interacting EBT timing with pre-period independent vendor share), the paper cannot disentangle whether the null result is due to resilient access or offsetting benefits from fraud reduction. The current strategy tests "EBT Effect," not "Vendor Exit Effect."
3.  **Outcome Measurement and Timing Alignment:** The paper defines treatment as EBT adoption lagged by two years to match CHR reporting windows. However, CHR documentation indicates data are centered approximately three years prior to release, with varying methodologies across years. This misalignment introduces measurement error in the treatment timing variable ($\text{EBT}_{st}$), biasing coefficients toward zero. Furthermore, relying solely on LBW (a tail outcome) ignores mean birth weight, which is often a more precise continuous measure of nutritional status.

## 4. Suggestions

The paper addresses a policy-relevant question with a clean narrative, but the empirical execution requires strengthening to meet the standards of *AER: Insights*. The following recommendations aim to align the paper closer to the original manifest's feasibility claims and robustly test the proposed mechanism.

**1. Upgrade to CDC Natality Microdata or County-Level Aggregates**
The most critical improvement would be accessing the data originally proposed in the manifest. The National Center for Health Statistics (NCHS) Restricted Use Data or the CDC WONDER detailed tables provide county-level birth records.
*   **Action:** Apply for access to the NCHS Restricted Use Data or utilize the CDC WONDER "Natality" detailed files which allow for county-level stratification.
*   **Benefit:** This increases the number of observations from 765 (state-year) to potentially hundreds of thousands (county-year). It allows for the inclusion of county fixed effects, controlling for time-invariant local health infrastructure. It also enables the proposed Ohio analysis (Manifest Strategy 3), which offers within-state variation that is immune to state-level confounding policies (e.g., Medicaid expansion).
*   **Implementation:** If microdata access is delayed, use the CDC WONDER "Births by County" tables which provide counts of low birth weight and total births by county-year. Construct the LBW rate directly rather than relying on CHR smoothed estimates.

**2. Implement the Bartik IV Strategy to Isolate Vendor Exits**
To claim the paper tests the "Infrastructure Access Multiplier," you must isolate the variation in EBT adoption that specifically drives vendor exits.
*   **Action:** Construct a shift-share instrument as proposed in the manifest. Let $Share_{s,0}$ be the pre-period share of independent (non-chain) WIC vendors in state $s$. Interact this with the state's EBT adoption timing: $Z_{st} = Share_{s,0} \times \text{PostEBT}_{st}$.
*   **Rationale:** States with higher reliance on independent vendors should experience larger access shocks upon EBT adoption. If the coefficient on this instrumented variable is null, you can more confidently claim that *vendor loss specifically* does not harm health, rather than just claiming *EBT* does not harm health.
*   **Data Source:** Use the USDA FNS WIC Vendor Data (available via FOIA or aggregated reports) to construct the independent vendor share by state pre-2004.

**3. Expand Outcome Variables and Precision**
Low birth weight is a binary threshold (<2500g) that may miss shifts in the distribution.
*   **Action:** Include mean birth weight (grams) and the preterm birth rate (<37 weeks) as primary outcomes.
*   **Rationale:** Mean birth weight is a continuous variable with higher statistical power to detect small nutritional shifts. Preterm birth is a distinct physiological outcome often linked to stress and access barriers, complementary to LBW.
*   **Breastfeeding:** If using CDC microdata, include the breastfeeding initiation indicator from the birth certificate (available in most states post-2003). This is a direct measure of postpartum support often provided at WIC clinics.

**4. Clarify Timing and Address CHR Smoothing**
If the authors must retain CHR data, the timing construction needs rigorous defense.
*   **Action:** Explicitly map the CHR release year to the underlying vital statistics year. For example, CHR 2010 data often reflects 2007-2009 averages. Ensure the $\text{EBT}_{st}$ indicator aligns with the *measurement period*, not the *release year*.
*   **Sensitivity:** Run a sensitivity analysis assuming different lag structures (1-year, 2-year, 3-year) to show the null result is not an artifact of misaligned timing. Consider using the Rambachan-Roth sensitivity analysis not just for parallel trends, but to bound the potential attenuation bias from measurement error.

**5. Heterogeneity Analysis: Rural vs. Urban**
The anecdotal introduction highlights a mother in rural Mississippi. The state-level average may mask localized harm.
*   **Action:** Interact the treatment effect with a measure of rural status (e.g., USDA Rural-Urban Continuum Codes) or pre-period vendor density (vendors per capita).
*   **Rationale:** If vendor exits matter, they should matter most where substitutes are scarce. Finding a null effect in urban areas but a positive effect (harm) in rural areas would nuance the conclusion significantly. This aligns with the manifest's interest in "infrastructure-mediated program access."

**6. Discussion of Power and Minimum Detectable Effects**
Given the state-level aggregation, explicitly calculate the Minimum Detectable Effect (MDE).
*   **Action:** Report the MDE for the main specification at 80% power.
*   **Rationale:** If the MDE is 0.5 percentage points (a large shift in LBW), the null result is less informative. If the MDE is 0.05 percentage points, the null is precise. This helps readers interpret whether "no evidence of harm" means "no harm" or "too noisy to tell."

**7. Refine the Contribution Statement**
Currently, the paper claims to test the "Infrastructure Access Multiplier." Without the vendor-specific identification (Suggestion 2), this claim is overstated.
*   **Action:** Temper the contribution to focus on "Safety Net Modernization and Health" rather than specifically vendor infrastructure, unless the IV strategy is implemented. Alternatively, frame the null result as evidence of participant resilience (substitution to chains) rather than infrastructure irrelevance.

By implementing these suggestions, particularly the data upgrade and the mechanism-specific IV, the paper would fulfill the promise of the original idea manifest and provide a definitive answer to the policy question posed. The current draft is a solid start but reads more like a preliminary state-level check than the comprehensive evaluation proposed.
